Sponsored By

Foster will provide application development, sales, and technical support for the thermoplastic polyurethane (TPU) products in the North American medical market.

May 24, 2022

1 Min Read
miniature workmen lowering puzzle piece into puzzle
Image courtesy of Alamy/fStop Images GmbH

Foster Corp. announced today its appointment as marketing partner for AdvanSource Biomaterials, a developer of specialty thermoplastic polyurethane (TPU) products for specific application requirements. Foster’s role will entail application development, sales, and technical support of AdvanSource products in the North American healthcare market. AdvanSource Biomaterials, based in Wilmington, MA, is a group company of Mitsubishi Chemical.

AdvanSource Biomaterials offers TPU products for implantable and non-implantable healthcare applications. Its TPU technologies include polycarbonate aliphatic, polycarbonate aromatic, polyether aromatic, aliphatic ether, hydrophilic, as well as polycarbonate silicone elastomers and soft aromatic polyurethane alloys. Healthcare application segments include cardiology, orthopedics, drug delivery, endoscopy, wound care, urology, and neurology.

Foster and AdvanSource have had a long sales and marketing relationship, said Larry Acquarulo, President and Owner of Foster, noting his admiration of the company. “We are actually a customer of AdvanSource and have always been impressed with the quality of their product and their breadth of technology and elastomer solutions,” said Acquarulo. “Foster processes and sells materials for implantable applications, which is also a market that AdvanSource participates in. This parallel interest makes this partnership a great match.”

Foster will distribute and support the AdvanSource TPUs from its two US locations in Connecticut and Nevada.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like